Cargando…
The Efficacy of Naïve versus Modified Mesenchymal Stem Cells in Improving Muscle Function in Duchenne Muscular Dystrophy: A Systematic Review
As one of the most common genetic conditions, Duchenne muscular dystrophy (DMD) is a fatal disease caused by a recessive mutation resulting in muscle weakness in both voluntary and involuntary muscles and, eventually, in death because of cardiovascular failure. Currently, there is no pharmacological...
Autores principales: | Shen, Oscar Yuan-Jie, Chen, Yi-Fan, Xu, Hong-Tao, Lee, Chien-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467288/ https://www.ncbi.nlm.nih.gov/pubmed/34572283 http://dx.doi.org/10.3390/biomedicines9091097 |
Ejemplares similares
-
A Systematic Review on the Role of SIRT1 in Duchenne Muscular Dystrophy
por: Domi, Elisa, et al.
Publicado: (2021) -
Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy
por: Barp, Andrea, et al.
Publicado: (2015) -
Genetic Modifiers of Duchenne Muscular Dystrophy in Chinese Patients
por: Chen, Menglong, et al.
Publicado: (2020) -
Genetic modifiers of respiratory function in Duchenne muscular dystrophy
por: Bello, Luca, et al.
Publicado: (2020) -
Global prevalence of Duchenne and Becker muscular dystrophy: a systematic review and meta-analysis
por: Salari, Nader, et al.
Publicado: (2022)